Background: The most effective contacts in subthalamic nucleus (STN) deep brain stimulation are reported to be dorsolateral, and suppression of synchronized oscillatory activity might be a mechanism of action. Objectives: To analyze the optimal contact position in regard to the anatomical and electrophysiological position and to determine whether oscillatory and bursty activity is more frequent around the active contact. Methods: In 21 patients, the clinically most effective contacts were analyzed according to their relative position to the anatomical and electrophysiological STN center, which was assessed by T2-weighted MRI and microrecording. In 12 out of 21 consecutive patients, autocorrelograms of the action potentials within the vicinity of the active contact were compared to the most ventromedial reference contact. Results: The isocenter of the anatomical and electrophysiological STN had a mean deviation of 0.8 mm (SD 1.45). Thirty-two out of 42 active contacts were found dorsal to the anatomical isocenter of the STN. None of the active contacts were ventral to the STN. Synchronized oscillatory or bursty activity was found in 67% of the patients within the vicinity of the active contact. In 64% of the patients, the ventromedial reference contact showed irregular activity. Conclusions: Synchronized activity in the autocorrelogram correlates with the most effective contact. The optimal localization of the finally stimulated contact is dorsal to the STN isocenter.

1.
Benabid AL, Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao DM, Laurent A, Gentil M, Perret J: Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg 1994;62:76-84.
2.
Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J: A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
3.
Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934.
4.
Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J: Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2010;81:315-319.
5.
Monakow KH, Akert K, Kunzle H: Projections of the precentral motor cortex and other cortical areas of the frontal lobe to the subthalamic nucleus in the monkey. Exp Brain Res 1978;33:395-403.
6.
DeLong MR, Crutcher MD, Georgopoulos AP: Primate globus pallidus and subthalamic nucleus: functional organization. J Neurophysiol 1985;53:530-543.
7.
Rodriguez-Oroz MC, Rodriguez M, Guridi J, Mewes K, Chockkman V, Vitek J, DeLong MR, Obeso JA: The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain 2001;124:1777-1790.
8.
Abosch A, Hutchison WD, Saint-Cyr JA, Dostrovsky JO, Lozano AM: Movement-related neurons of the subthalamic nucleus in patients with Parkinson disease. J Neurosurg 2002;97:1167-1172.
9.
Hamel W, Fietzek U, Morsnowski A, Schrader B, Weinert D, Muller D, Deuschl G, Mehdorn HM: Subthalamic nucleus stimulation in Parkinson's disease: correlation of active electrode contacts with intraoperative microrecordings. Stereotact Funct Neurosurg 2003;80:37-42.
10.
Voges J, Volkmann J, Allert N, Lehrke R, Koulousakis A, Freund HJ, Sturm V: Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg 2002;96:269-279.
11.
Yokoyama T, Ando N, Sugiyama K, Akamine S, Namba H: Relationship of stimulation site location within the subthalamic nucleus region to clinical effects on parkinsonian symptoms. Stereotact Funct Neurosurg 2006;84:170-175.
12.
Marsden JF, Limousin-Dowsey P, Ashby P, Pollak P, Brown P: Subthalamic nucleus, sensorimotor cortex and muscle interrelationships in Parkinson's disease. Brain 2001;124:378-388.
13.
Chen CC, Pogosyan A, Zrinzo LU, Tisch S, Limousin P, Ashkan K, Yousry T, Hariz MI, Brown P: Intra-operative recordings of local field potentials can help localize the subthalamic nucleus in Parkinson's disease surgery. Exp Neurol 2006;198:214-221.
14.
Eusebio A, Thevathasan W, Doyle Gaynor L, Pogosyan A, Bye E, Foltynie T, Zrinzo L, Ashkan K, Aziz T, Brown P: Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J Neurol Neurosurg Psychiatry 2011;82:569-573.
15.
Zaidel A, Spivak A, Shpigelman L, Bergman H, Israel Z: Delimiting subterritories of the human subthalamic nucleus by means of microelectrode recordings and a Hidden Markov model. Mov Disord 2009;24:1785-1793.
16.
Seifried C, Weise L, Hartmann R, Gasser T, Baudrexel S, Szelenyi A, van de Loo S, Steinmetz H, Seifert V, Roeper J, Hilker R: Intraoperative microelectrode recording for the delineation of subthalamic nucleus topography in Parkinson's disease. Brain stimulation 2012;5:378-387.
17.
Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang AE, Lozano AM: Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998;44:622-628.
18.
Wilson CJ, Young SJ, Groves PM: Statistical properties of neuronal spike trains in the substantia nigra: cell types and their interactions. Brain Res 1977;136:243-260.
19.
Brazhnik E, Shah F, Tepper JM: Gabaergic afferents activate both GABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo. J Neurosci 2008;28:10386-10398.
20.
Schaltenbrand G, Wahren W: Atlas for Stereotaxy of the Human Brain. Stuttgart, New York, Thieme, 1977.
21.
Foltynie T, Zrinzo L, Martinez-Torres I, Tripoliti E, Petersen E, Holl E, Aviles-Olmos I, Jahanshahi M, Hariz M, Limousin P: MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry 2011;82:358-363.
22.
Godinho F, Thobois S, Magnin M, Guenot M, Polo G, Benatru I, Xie J, Salvetti A, Garcia-Larrea L, Broussolle E, Mertens P: Subthalamic nucleus stimulation in Parkinson's disease: anatomical and electrophysiological localization of active contacts. J Neurol 2006;253:1347-1355.
23.
Coenen VA, Abdel-Rahman A, McMaster J, Bogod N, Honey CR: Minimizing brain shift during functional neurosurgical procedures - a simple burr hole technique that can decrease CSF loss and intracranial air. Cent Eur Neurosurg 2011;72:181-185.
24.
Bour LJ, Contarino MF, Foncke EM, de Bie RM, van den Munckhof P, Speelman JD, Schuurman PR: Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi. Acta Neurochir (Wien) 2010;152:2069-2077.
25.
Shin M, Penholate MF, Lefaucheur JP, Gurruchaga JM, Brugieres P, Nguyen JP: Assessing accuracy of the magnetic resonance imaging-computed tomography fusion images to evaluate the electrode positions in subthalamic nucleus after deep-brain stimulation. Neurosurgery 2010;66:1193-1202, discussion 1202.
26.
Morel A, Magnin M, Jeanmonod D: Multiarchitectonic and stereotactic atlas of the human thalamus. J Comp Neurol 1997;387:588-630.
27.
Plaha P, Ben-Shlomo Y, Patel NK, Gill SS: Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 2006;129:1732-1747.
28.
Kitagawa M, Murata J, Uesugi H, Kikuchi S, Saito H, Tashiro K, Sawamura Y: Two-year follow-up of chronic stimulation of the posterior subthalamic white matter for tremor-dominant Parkinson's disease. Neurosurgery 2005;56:281-289, discussion 281-289.
29.
Steigerwald F, Potter M, Herzog J, Pinsker M, Kopper F, Mehdorn H, Deuschl G, Volkmann J: Neuronal activity of the human subthalamic nucleus in the parkinsonian and nonparkinsonian state. J Neurophysiol 2008;100:2515-2524.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.